These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


212 related items for PubMed ID: 27605635

  • 1. Eligibility For And Enrollment In Medicare Part D Medication Therapy Management Programs Varies By Plan Sponsor.
    Stuart B, Hendrick FB, Shen X, Dai M, Tom SE, Dougherty JS, Miller LM.
    Health Aff (Millwood); 2016 Sep 01; 35(9):1572-80. PubMed ID: 27605635
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of an integrated adherence program aimed to increase Medicare Part D star rating measures.
    Leslie RS, Tirado B, Patel BV, Rein PJ.
    J Manag Care Spec Pharm; 2014 Dec 01; 20(12):1193-203. PubMed ID: 25443513
    [Abstract] [Full Text] [Related]

  • 3. PDP or MA-PD? Medicare part D enrollment decisions in CMS Region 25.
    Cline RR, Worley MM, Schondelmeyer SW, Schommer JC, Larson TA, Uden DL, Hadsall RS.
    Res Social Adm Pharm; 2010 Jun 01; 6(2):130-42. PubMed ID: 20511112
    [Abstract] [Full Text] [Related]

  • 4. Improving Comprehensive Medication Review Acceptance by Using a Standardized Recruitment Script: A Randomized Control Trial.
    Miguel A, Hall A, Liu W, Garrett J, Ballew A, Yang TH, Segal R.
    J Manag Care Spec Pharm; 2017 Jan 01; 23(1):13-21. PubMed ID: 28025924
    [Abstract] [Full Text] [Related]

  • 5. Economic assessment of changes to an existing medication therapy management program of a large regional health plan.
    Peasah SK, Hammonds T, Liu Y, Campbell V, Manolis C, Good CB.
    J Manag Care Spec Pharm; 2021 Feb 01; 27(2):147-156. PubMed ID: 33506728
    [Abstract] [Full Text] [Related]

  • 6. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM, Urmie JM, Farris KB, Doucette WR.
    Res Social Adm Pharm; 2010 Jun 01; 6(2):100-9. PubMed ID: 20511109
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of Eligibility Criteria Used to Identify Patients for Medication Therapy Management Services: A Retrospective Cohort Study in a Medicare Advantage Part D Population.
    Lee JS, Yang J, Stockl KM, Lew H, Solow BK.
    J Manag Care Spec Pharm; 2016 Jan 01; 22(1):22-30. PubMed ID: 27015048
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Medicare Part D: selected issues for plan sponsors, pharmacists, and beneficiaries in 2009.
    Stubbings J, DePue RJ.
    Am J Manag Care; 2009 Sep 01; 15(9):645-9. PubMed ID: 19747029
    [Abstract] [Full Text] [Related]

  • 10. Medicare Prescription Drug Plan Enrollees Report Less Positive Experiences Than Their Medicare Advantage Counterparts.
    Elliott MN, Landon BE, Zaslavsky AM, Edwards C, Orr N, Beckett MK, Mallett J, Cleary PD.
    Health Aff (Millwood); 2016 Mar 01; 35(3):456-63. PubMed ID: 26953300
    [Abstract] [Full Text] [Related]

  • 11. Medicare Part D: early findings on enrollment and choices for rural beneficiaries.
    McBride TD, Terry TL, Mueller KJ.
    Rural Policy Brief; 2006 Apr 01; 10(8 (PB2006-8)):1-9. PubMed ID: 16685809
    [Abstract] [Full Text] [Related]

  • 12. Impact of an open enrollment service on costs for Medicare Part D beneficiaries.
    Leonard CE, Cohenour FV, DeLoach LA, Galdo JA.
    J Am Pharm Assoc (2003); 2017 Apr 01; 57(3S):S225-S228. PubMed ID: 28412055
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Estimating Medicare Part D's impact on medication access among dually eligible beneficiaries with mental disorders.
    Donohue JM, Frank RG.
    Psychiatr Serv; 2007 Oct 01; 58(10):1285-91. PubMed ID: 17914004
    [Abstract] [Full Text] [Related]

  • 16. Medicare Part D roulette: potential implications of random assignment and plan restrictions.
    Patel RA, Walberg MP, Woelfel JA, Amaral MM, Varu P.
    Medicare Medicaid Res Rev; 2013 Oct 01; 3(2):. PubMed ID: 24753963
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Impact of final short-fill rule on Medicare Part D costs and long-term care pharmacy dispensing.
    Bazalo G, Weiss RC.
    Consult Pharm; 2012 Apr 01; 27(4):269-73. PubMed ID: 22498986
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.